Advanced Enzyme Technologies Balance Sheet Health
Financial Health criteria checks 6/6
Advanced Enzyme Technologies has a total shareholder equity of ₹13.7B and total debt of ₹473.1M, which brings its debt-to-equity ratio to 3.5%. Its total assets and total liabilities are ₹15.4B and ₹1.6B respectively. Advanced Enzyme Technologies's EBIT is ₹1.8B making its interest coverage ratio -17.4. It has cash and short-term investments of ₹5.3B.
Key information
3.5%
Debt to equity ratio
₹473.08m
Debt
| Interest coverage ratio | -17.4x |
| Cash | ₹5.29b |
| Equity | ₹13.71b |
| Total liabilities | ₹1.64b |
| Total assets | ₹15.35b |
Recent financial health updates
No updates
Recent updates
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar
Aug 20
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now
Jul 19Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Oct 06Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable
Sep 26Financial Position Analysis
Short Term Liabilities: ADVENZYMES's short term assets (₹8.1B) exceed its short term liabilities (₹1.1B).
Long Term Liabilities: ADVENZYMES's short term assets (₹8.1B) exceed its long term liabilities (₹580.3M).
Debt to Equity History and Analysis
Debt Level: ADVENZYMES has more cash than its total debt.
Reducing Debt: ADVENZYMES's debt to equity ratio has reduced from 5% to 3.5% over the past 5 years.
Debt Coverage: ADVENZYMES's debt is well covered by operating cash flow (298.8%).
Interest Coverage: ADVENZYMES earns more interest than it pays, so coverage of interest payments is not a concern.